Chinook Therapeutics Inc. .

05/19/2022 | Press release | Distributed by Public on 05/19/2022 00:15

Chinook Therapeutics Presents Updated Data from BION-1301 Phase 1/2 Trial in Patients with IgA Nephropathy (IgAN) and from Atrasentan Preclinical Mechanism of Action Studies at[...]